Florida Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Tech Today.

Press releases published on November 9, 2026

2 hours ago

Editas Medicine Announces Third Quarter 2026 Results and Business Updates

Indeterminate GlobeNewswire

2 hours ago

Nkarta Announces Initial Clinical Data for NKX019 in Myositis and Systemic Sclerosis at ACR Convergence

Indeterminate GlobeNewswire

2 hours ago

Roivant Reports Financial Results for the Second Quarter Ended September 30, 2026, and Provides Business Update

Indeterminate GlobeNewswire

2 hours ago

Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2026 Financial Results 

Indeterminate GlobeNewswire

2 hours ago

Ocular Therapeutix™ Reports Third Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire

2 hours ago

Atea Pharmaceuticals Secures Credit Facility for Up to $200 Million from Hercules Capital

Indeterminate GlobeNewswire

2 hours ago

Annovis Announces Closing of $21.0 Million Public Offering with 24% Contribution from the Board Chairman

Indeterminate GlobeNewswire

2 hours ago

Kamada Declares Cash Dividend of $0.14 Per Share; The Company Continues its Record-High Year

Indeterminate GlobeNewswire

2 hours ago

Mentari Therapeutics Announces Closing of Merger with InMed Pharmaceuticals and Previously Announced $490 Million Financing

Indeterminate GlobeNewswire

2 hours ago

CorMedix Therapeutics to Acquire Substantially All Assets of Heron Therapeutics, Expanding Its Portfolio of Products Used in Institutional Settings of Care

Indeterminate GlobeNewswire

2 hours ago

Tango Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Highlights

Indeterminate GlobeNewswire

2 hours ago

BlossomHill Therapeutics Announces Outcome from the End-of-Phase 1 Meeting with the FDA and Pivotal Phase 2 Trial Design for OMNI-EGFR™ Inhibitor, BH-30643, in EGFR C797S-Positive NSCLC

Indeterminate GlobeNewswire

2 hours ago

Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended September 30, 2026

Indeterminate GlobeNewswire

2 hours ago

Alternative Ballistics Provides Corporate Update Highlighting Commercialization Momentum and Expanding Distribution Network

Indeterminate GlobeNewswire

2 hours ago

Tiziana Life Sciences to Present at BIO-Europe 2026 and Host KOL Webcast

Indeterminate GlobeNewswire

2 hours ago

Can-Fite Reports Ten-Year Survival Milestone for Advanced Liver Cancer Patient from Phase II Namodenoson Study

Indeterminate GlobeNewswire

2 hours ago

Medicenna Presents ABILITY-1 Data at SITC 2026 Showing 40% ORR in Gastrointestinal Cancer Patients with Biomarker Enriched Tumors Resistant to Approved Therapies

Indeterminate GlobeNewswire

3 hours ago

Abeona Therapeutics® Reports Third Quarter 2026 Financial Results and ZEVASKYN® Commercial Progress

Indeterminate GlobeNewswire

3 hours ago

Abeona Therapeutics® Acquires Phase 3-Ready APT-1011, Now ABO-801, and Enters Into Agreement for $30 Million Private Placement

Indeterminate GlobeNewswire

3 hours ago

Meowant Announces Black Friday and Cyber Monday Sale With Upgraded Offers at Meowant.com

Indeterminate GlobeNewswire